Sernova Corp. (SVA.TO)
CAD 0.23
(0.0%)
CAD 0.23
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -41.13 Million CAD | -70.13% |
| 2022 | -24.17 Million CAD | -252.12% |
| 2021 | -6.86 Million CAD | -31.51% |
| 2020 | -5.22 Million CAD | -31.52% |
| 2019 | -3.96 Million CAD | -7.61% |
| 2018 | -3.68 Million CAD | -40.5% |
| 2017 | -2.62 Million CAD | -5.45% |
| 2016 | -2.48 Million CAD | 12.75% |
| 2015 | -2.85 Million CAD | -2.15% |
| 2014 | -2.79 Million CAD | -35.27% |
| 2013 | -2.06 Million CAD | 20.67% |
| 2012 | -2.6 Million CAD | -28.01% |
| 2011 | -2.03 Million CAD | -10.25% |
| 2010 | -1.84 Million CAD | -24.09% |
| 2009 | -1.48 Million CAD | 45.26% |
| 2008 | -2.71 Million CAD | 26.94% |
| 2007 | -3.71 Million CAD | -178.25% |
| 2006 | -1.33 Million CAD | -213.85% |
| 2005 | -425.66 Thousand CAD | 30.58% |
| 2004 | -613.21 Thousand CAD | 13.61% |
| 2003 | -709.85 Thousand CAD | 52.55% |
| 2002 | -1.49 Million CAD | 30.08% |
| 2001 | -2.13 Million CAD | -406.99% |
| 2000 | -422.08 Thousand CAD | -1280.21% |
| 1999 | -30.58 Thousand CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -10.08 Million CAD | 12.41% |
| 2024 Q3 | -7.09 Million CAD | 27.43% |
| 2024 Q2 | -9.85 Million CAD | 2.27% |
| 2023 Q4 | -11.51 Million CAD | -15.93% |
| 2023 Q2 | -9.4 Million CAD | -15.43% |
| 2023 Q3 | -9.93 Million CAD | -5.62% |
| 2023 Q1 | -8.14 Million CAD | -1.41% |
| 2023 FY | -41.13 Million CAD | -70.13% |
| 2022 FY | -24.17 Million CAD | -252.12% |
| 2022 Q3 | -5.79 Million CAD | -17.84% |
| 2022 Q1 | -5.44 Million CAD | -122.96% |
| 2022 Q2 | -4.91 Million CAD | 9.71% |
| 2022 Q4 | -8.03 Million CAD | -38.74% |
| 2021 FY | -6.86 Million CAD | -31.51% |
| 2021 Q1 | -1.17 Million CAD | -19.48% |
| 2021 Q3 | -1.63 Million CAD | 1.9% |
| 2021 Q4 | -2.44 Million CAD | -49.75% |
| 2021 Q2 | -1.66 Million CAD | -41.49% |
| 2020 Q2 | -1.72 Million CAD | -27.44% |
| 2020 Q1 | -1.35 Million CAD | 22.82% |
| 2020 Q4 | -982.95 Thousand CAD | 15.72% |
| 2020 Q3 | -1.16 Million CAD | 32.55% |
| 2020 FY | -5.22 Million CAD | -31.52% |
| 2019 Q3 | -873.33 Thousand CAD | -42.89% |
| 2019 Q1 | -721.67 Thousand CAD | 13.3% |
| 2019 FY | -3.96 Million CAD | -7.61% |
| 2019 Q4 | -1.75 Million CAD | -101.28% |
| 2019 Q2 | -611.18 Thousand CAD | 15.31% |
| 2018 Q1 | -762.99 Thousand CAD | 21.74% |
| 2018 FY | -3.68 Million CAD | -40.5% |
| 2018 Q4 | -832.37 Thousand CAD | 24.98% |
| 2018 Q3 | -1.1 Million CAD | -12.73% |
| 2018 Q2 | -984.29 Thousand CAD | -29.0% |
| 2017 Q2 | -634.35 Thousand CAD | -102.31% |
| 2017 Q1 | -313.55 Thousand CAD | -91.6% |
| 2017 FY | -2.62 Million CAD | -5.45% |
| 2017 Q4 | -974.93 Thousand CAD | -38.72% |
| 2017 Q3 | -702.8 Thousand CAD | -10.79% |
| 2016 Q3 | -961.99 Thousand CAD | -48.41% |
| 2016 Q4 | -163.65 Thousand CAD | 82.99% |
| 2016 FY | -2.48 Million CAD | 12.75% |
| 2016 Q1 | -662.45 Thousand CAD | 25.08% |
| 2016 Q2 | -648.19 Thousand CAD | 2.15% |
| 2015 Q4 | -884.23 Thousand CAD | -31.54% |
| 2015 Q2 | -682.88 Thousand CAD | -6.93% |
| 2015 Q3 | -672.24 Thousand CAD | 1.56% |
| 2015 Q1 | -638.64 Thousand CAD | 7.07% |
| 2015 FY | -2.85 Million CAD | -2.15% |
| 2014 Q3 | -756.14 Thousand CAD | 0.67% |
| 2014 FY | -2.79 Million CAD | -35.27% |
| 2014 Q4 | -687.19 Thousand CAD | 9.12% |
| 2014 Q2 | -761.26 Thousand CAD | -25.02% |
| 2014 Q1 | -608.92 Thousand CAD | -9.75% |
| 2013 Q4 | -554.82 Thousand CAD | -39.66% |
| 2013 Q2 | -569.51 Thousand CAD | -4.78% |
| 2013 Q1 | -543.54 Thousand CAD | 22.4% |
| 2013 FY | -2.06 Million CAD | 20.67% |
| 2013 Q3 | -397.25 Thousand CAD | 30.25% |
| 2012 FY | -2.6 Million CAD | -28.01% |
| 2012 Q1 | -627.71 Thousand CAD | -25.92% |
| 2012 Q4 | -700.41 Thousand CAD | -18.96% |
| 2012 Q2 | -686.49 Thousand CAD | -9.36% |
| 2012 Q3 | -588.76 Thousand CAD | 14.24% |
| 2011 Q1 | -525.32 Thousand CAD | -6.36% |
| 2011 FY | -2.03 Million CAD | -10.25% |
| 2011 Q4 | -498.51 Thousand CAD | -13.04% |
| 2011 Q3 | -441 Thousand CAD | 22.48% |
| 2011 Q2 | -568.86 Thousand CAD | -8.29% |
| 2010 FY | -1.84 Million CAD | -24.09% |
| 2010 Q2 | -425.52 Thousand CAD | 5.04% |
| 2010 Q3 | -478.27 Thousand CAD | -12.4% |
| 2010 Q4 | -493.9 Thousand CAD | -3.27% |
| 2010 Q1 | -448.1 Thousand CAD | 3.09% |
| 2009 Q2 | -384.08 Thousand CAD | -38.33% |
| 2009 FY | -1.48 Million CAD | 45.26% |
| 2009 Q3 | -339.82 Thousand CAD | 11.52% |
| 2009 Q4 | -462.41 Thousand CAD | -36.07% |
| 2009 Q1 | -277.66 Thousand CAD | 50.77% |
| 2008 Q1 | -644.19 Thousand CAD | 37.45% |
| 2008 Q4 | -564.06 Thousand CAD | -13.77% |
| 2008 FY | -2.71 Million CAD | 26.94% |
| 2008 Q3 | -495.77 Thousand CAD | 54.98% |
| 2008 Q2 | -1.1 Million CAD | -70.96% |
| 2007 Q4 | -1.02 Million CAD | 6.01% |
| 2007 Q3 | -1.09 Million CAD | 4.69% |
| 2007 Q1 | -454.31 Thousand CAD | -15003.56% |
| 2007 Q2 | -1.14 Million CAD | -153.09% |
| 2007 FY | -3.71 Million CAD | -178.25% |
| 2006 Q4 | -3008.00 CAD | 97.2% |
| 2006 FY | -1.33 Million CAD | -213.85% |
| 2006 Q2 | -1.13 Million CAD | -1028.35% |
| 2006 Q3 | -107.38 Thousand CAD | 90.51% |
| 2006 Q1 | -100.3 Thousand CAD | -13.06% |
| 2005 Q1 | -80.73 Thousand CAD | 52.95% |
| 2005 Q2 | -158.24 Thousand CAD | -96.0% |
| 2005 Q3 | -77.42 Thousand CAD | 51.07% |
| 2005 Q4 | -88.71 Thousand CAD | -14.58% |
| 2005 FY | -425.66 Thousand CAD | 30.58% |
| 2004 FY | -613.21 Thousand CAD | 13.61% |
| 2004 Q4 | -171.61 Thousand CAD | -77.03% |
| 2004 Q3 | -96.94 Thousand CAD | 41.08% |
| 2004 Q2 | -164.54 Thousand CAD | 8.65% |
| 2004 Q1 | -180.11 Thousand CAD | -86.09% |
| 2003 Q1 | -280.29 Thousand CAD | -16.04% |
| 2003 Q3 | -85.45 Thousand CAD | 65.45% |
| 2003 FY | -709.85 Thousand CAD | 52.55% |
| 2003 Q4 | -96.78 Thousand CAD | -13.26% |
| 2003 Q2 | -247.31 Thousand CAD | 11.76% |
| 2002 FY | -1.49 Million CAD | 30.08% |
| 2002 Q3 | -324.83 Thousand CAD | 30.52% |
| 2002 Q2 | -467.51 Thousand CAD | -1.14% |
| 2002 Q1 | -462.24 Thousand CAD | 0.0% |
| 2002 Q4 | -241.55 Thousand CAD | 25.64% |
| 2001 FY | -2.13 Million CAD | -406.99% |
| 2000 FY | -422.08 Thousand CAD | -1280.21% |
| 1999 FY | -30.58 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Appili Therapeutics Inc. | -8.05 Million CAD | -410.927% |
| Eupraxia Pharmaceuticals Inc. | -36.89 Million CAD | -11.475% |
| Helix BioPharma Corp. | -9.37 Million CAD | -338.914% |
| Microbix Biosystems Inc. | -2.73 Million CAD | -1403.075% |
| Medicenna Therapeutics Corp. | -19.66 Million CAD | -109.178% |
| Satellos Bioscience Inc. | -15.46 Million CAD | -165.994% |
| Oncolytics Biotech Inc. | -33.79 Million CAD | -21.721% |